CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES >
Expression and angiogenic effect of VEGFA/VEGFR2 in mice hepatic metacestode tissue of Echinococcus multilocularis
Received date: 2020-05-08
Online published: 2021-01-12
Supported by
National Natural Science Foundation of China(81760570);National Natural Science Foundation of China(81760371);Xinjiang Production and Construction Corps Special Fund for Scientific and Technological Development(2018CB017);Xinjiang Production and Construction Corps Special Fund for Scientific and Technological Development(2019AB031)
Objective To detect the mRNA and protein levels of VEGFA and VEGFR2 in mouse liver tissue and liver cells of mouse infected with Echinococcus multilocularis(Em), in order to explore the roles of vascular endothelial growth factor A (VEGFA) and endothelial growth factor receptor 2 (VEGFR2) in tissue angiogenesis. Methods Twenty female C57BL/6 mice were randomly divided into two groups, the experimental group and the control group, 10 animals each. Each mouse in the experimental group was directly injected Em metacestodes into the liver, while the control group mice were injected with PBS in the same way. Sera were separated from the whole blood of mice on days 0, 16, 37, 58, 81, and 105 after infection. The mice were euthanized on day 120 to observe the growing status of metacestode and collect. Metacestode tissue, liver tissue around metacestode, and normal liver tissue of control group mice for examining the angiogenesis in metacestode tissue by HE staining. The expression and distribution of VEGFA and VEGFR2 in these tissue samples were detected by immunohistochemistry. The liver cells and protoscoleces were sampled for in vitro incubation in three groups in 12 Petri dishes each group, comprising the group of liver cells-protoscoleces co-incubation, liver cells and protoscoleces. The culture supernatant, liver cells and protoscoleces in each group were collected on incubation day 1, 2 and 3 to assay the levels of VEGFA, VEGFR2 mRNA and protein in normal liver tissue, metacestode tissue, liver tissues around metacestode within 4 mm, and liver cells after co-incubation with protoscoleces using qRT-PCR and Western blotting. ELISA was performed to detect the content of VEGFA in peripheral blood, as well as the protein levels of VEGFA in normal liver tissue, metacestode tissue, liver tissue around metacestode, as well as in the culture supernatant of the co-incubation group, the liver cell group and the protoscolex group. Results qRT-PCR showed that the relative transcription levels of VEGFA mRNA in healthy liver tissues, liver tissues around metacestode, and metacestode tissue were 1.033 ± 0.102, 1.222 ± 0.501, and 0.276 ± 0.092, respectively. The relative transcription level of VEGFA in metacestode tissue was lower than those in the normal liver tissue and the liver tissue around metacestode (P < 0.05); while the transcription of VEGFR2 mRNA was 1.042 ± 0.071, 1.836 ± 0.062, and 0.226 ± 0.077, respectively. In comparision, the relative transcription level of VEGFR2 in the liver tissue around metacestode was higher than that in normal liver tissue (P < 0.01), whereas the transcription in metacestode tissue was lower than those in the normal liver tissue and the liver tissue around metacestode (P < 0.01). Western blotting showed that the proteins of GAPDH, VEGFA and VEGFR2 were not detected in the protein extracts of metacestode tissue, while the relative expression of VEGFA protein in the liver tissue around metacestode and normal liver tissues were 0.920 ± 0.096 and 0.816 ± 0.129, and those of VEGFR2 protein in the two groups were 1.439 ± 0.160 and 0.515 ± 0.022, respectively (P < 0.05). ELISA indicated that the content of VEGFA in the normal liver tissue, liver tissue around metacestode, and metacestode tissue was (6.581 ± 0.722), (6.363 ± 0.638), and (0.670 ± 0.105) pg, respectively. The immunohistochemical assay for VEGFA by scoring showed the scores of normal liver tissue, liver tissue around metacetode, and metacestode tissue was 3.552 ± 0.683, 3.355 ± 0.807, and 9.450 ± 1.292, respectively, revealing the expression of VEGFA in metacestode tissue being higher than those in the other two liver tissue samples (P < 0.05); while the assay for VEGFR2 scored 0.361 ± 0.547, 4.093 ± 1.042, 5.275 ± 1.003, respectively, with the expressionlevel in metacestode tissue being the highest among the three tissue samples (P < 0.01). ELISA results presented that the VEGFA level in peripheral blood on days 0, 16, 37, 58, 81, and 105 of the experimental group was (73.233 ± 7.651), (156.925 ± 5.111), (176.571 ± 40.343), (204.212 ± 9.601), (201.335 ± 24.161) and (185.745 ± 37.902) pg/ml, respectively, which were significantly higher than those of the control group of (70.355 ± 24.751), (56.144 ± 14.736), (81.094 ± 13.753), (76.172 ± 5.689), (64.393 ± 19.060) and (70.871 ± 23.966) pg/ml, respectively(P < 0.05). qRT-PCR results showed that the relative transcription levels of VEGFA and VEGFR2 mRNA on day 2 of the co-incubation group were 9.380 ± 1.165 and 2.764 ± 0.871, respectively, indicating significantly higher than those of the liver cell group of 1.028 ± 0.252 and 1.062 ± 0.201, respectively(P < 0.05). Western blotting showed that the relative expression levels of VEGFA and VEGFR2 protein on day 2 in the co-incubation group were 1.500 ± 0.148 and 1.540 ± 0.079, respectively, while those in the liver cell group were 1.322 ± 0.050 and 0.303 ± 0.003, and the expression levels in the metacestode group were higher than those in the liver vell group (P < 0.01). ELISA demonstrated that the content of VEGFA in the culture supernatant liver cell group on the incubation day 1, 2, and 3 was (24.923 ± 1.427), (151.760 ± 4.282), and (223.033 ± 10.061) pg/ml, respectively, all significantly lower than those in the co-incubation group (P < 0.01), which were (95.218 ± 4.932), (240.295 ± 15.121) and (366.148 ± 4.822) pg/ml, respectively. Conclusion E. multilocularis infection induces host cells to continuously express VEGFA, which spreads to the surrounding tissue by secretion enters the blood circulation, and further inducing the peripheral cells to highly express VEGFR2 targeting to the infection site, promoting angiogenesis in metacestode tissue.
Hui-jiao JIANG , Xian-wei GUI , Li-jiao GUO , Xiong-feng YANG , Xiao-yi WANG , Xue-ling CHEN , Xiang-wei WU . Expression and angiogenic effect of VEGFA/VEGFR2 in mice hepatic metacestode tissue of Echinococcus multilocularis[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2020 , 38(6) : 673 -681 . DOI: 10.12140/j.issn.1000-7423.2020.06.001
| [1] | Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern[J]. Clin Microbiol Rev, 2004,17(1):107-135. |
| [2] | Pang NN, Zhang FB, Ma XM, et al. TGF-β/Smad signaling pathway regulates Th17/Treg balance during Echinococcus multilocularis infection[J]. Int Immunopharmacol, 2014,20(1):248-257. |
| [3] | Brehm K. The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and host-parasite interaction[J]. Med Microbiol Immunol, 2010,199(3):247-259. |
| [4] | Sasaki F, Ohkawa Y, Sato N, et al. Imaging diagnosis of alveolar echinococcosis in young patients[J]. Pediatr Radiol, 1997,27(1):63-66. |
| [5] | Zhang SJ, Wu HX, Li Q, et al. Expressions of MVD-CD34 and VEGF in hepatic alveolar hydatid tissue in gerbil model and their clinical signii cances[J]. Chin J Bases Clin Gen Surg, 2015,22(2):134-138. (in Chinese) |
| [5] | ( 张示杰, 吴何兴, 李琪, 等. 沙鼠肝多房棘球蚴组织中微血管密度、血管内皮生长因子及意义[J]. 中国普外基础与临床杂志, 2015,22(2):134-138.) |
| [6] | Aydinli B, Aydin U, Yazici P, et al. Alveolar echinococcosis of liver presenting with neurological symptoms due to brain metastases with simultaneous lung metastasis: a case report[J]. Turkiye Parazitol Derg, 2008,32(4):371-374. |
| [7] | Kantarci M, Bayraktutan U, Karabulut N, et al. Alveolar echinococcosis: spectrum of findings at cross-sectional imaging[J]. Radiographics, 2012,32(7):2053-2070. |
| [8] | Falcon BL, Chintharlapalli S, Uhlik MT, et al. Antagonist antibodies to vascular endothelial growth factor receptor 2 (VEGFR-2) as anti-angiogenic agents[J]. Pharmacol Ther, 2016,164:204-225. |
| [9] | Claesson-Welsh L, Welsh M. VEGFA and tumour angiogenesis[J]. J Intern Med, 2013,273(2):114-127. |
| [10] | Zhang DM, Qing C. Vascular endothelial growth factor family and tumor angiogenesis[J]. Med Recap, 2017,23(3):417-420, 427. (in Chinese) |
| [10] | ( 张东梅, 卿晨. 血管内皮生长因子家族及其受体与肿瘤血管新生[J]. 医学综述, 2017,23(3):417-420, 427.) |
| [11] | Shibuya M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti-and pro-angiogenic therapies[J]. Gen Cancer, 2011,2(12):1097-1105. |
| [12] | Keklikoglou I, Kadioglu E, Bissinger S, et al. Periostin limits tumor response to VEGFA inhibition[J]. Cell Rep, 2018,22(10):2530-2540. |
| [13] | Yao B, Wang HT, Liu WY, et al. Peripheral zone of hepatic alveolar echinococcosis: CT perfusion and pathology[J]. Chin Comput Med Imaging, 2010,16(3):215-220. (in Chinese) |
| [13] | ( 姚冰, 王海涛, 刘文亚, 等. 肝泡球蚴病边缘区域CT灌注成像与组织病理对照研究[J]. 中国医学计算机成像杂志, 2010,16(3):215-220.) |
| [14] | Co?kun A, ?ztürk M, Karahan OI, et al. Alveolar echinococcosis of the liver: correlative color Doppler US, CT, and MRI study[J]. Acta Radiol, 2004,45(5):492-498. |
| [15] | Yang J, Bai JH, Zhang YH, et al. Revolution CT hepatic perfusion imaging assessment of peripheral infiltration zone of hepatic alveolar echinococcosis[J]. Chin J Schisto Control, 2018,30(6):678-681. (in Chinese) |
| [15] | ( 杨晶, 白峻虎, 张永海, 等. Revolution CT全肝灌注对肝多房棘球蚴病病灶边缘浸润带的影像学评估[J]. 中国血吸虫病防治杂志, 2018,30(6):678-681.) |
| [16] | Zhou Q, Yang XF, Han HH, et al. Correlation between angiogenesis and disease progression of hepatic Echinococcus multilocularis in C57BL/6 mice[J]. Chin J Parasitol Parasit Dis, 2019,37(3):302-310. (in Chinese) |
| [16] | ( 周青, 杨雄峰, 韩欢欢, 等. 小鼠肝多房棘球蚴中血管新生与病程发展的相关性研究[J]. 中国寄生虫学与寄生虫病志, 2019,37(3):302-310.) |
| [17] | Guo LJ, Jiang HJ, Han HH, et al. Expression of HIF-1α and VEGFA in hepatic alveolar echinococcosis and its effect on angiogenesis[J]. Chin J zoonoses, 2019,35(7):639-646. (in Chinese) |
| [17] | ( 郭黎姣, 姜慧娇, 韩欢欢, 等. 肝多房棘球蚴组织中HIF-1α、VEGFA的表达及对血管生成的作用[J]. 中国人兽共患病学报, 2019,35(7):639-646.) |
| [18] | Song T, Li HT, Yang LF, et al. Contrast-enhanced ultrasonography of hepatic alveolar echinococcosis in rats: the correaltion of imaging fratures and histologic microvascular density[J]. Chin J Parasitol Parasit Dis, 2014,32(3):200-204. (in Chinese) |
| [18] | ( 宋涛, 李海涛, 杨凌菲, 等. 大鼠肝泡球蚴病灶浸润增殖区微血管密度与超声造影的相关性研究[J]. 中国寄生虫学与寄生虫病杂志, 2014,32(3):200-204.) |
| [19] | Shen GH, Kou Y, Kuang AR. Doughnut sign of hepatic alveolar echinococcosis on FDG PET/CT: clinical case report[J]. Medicine, 2019,98(8):e14561. |
| [20] | Vogrin AJ, Bower NI, Gunzburg MJ, et al. Evolutionary differences in the vegf/vegfr code reveal organotypic roles for the endothelial cell receptor kdr in developmental lymphangiogenesis[J]. Cell Rep, 2019,28(8):2023-2036. |
| [21] | Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development[J]. Cell, 2019,176(6):1248-1264. |
| [22] | Sun Y, Jin K, Childs JT, et al. Vascular endothelial growth factor-B(VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration[J]. Dev Biol, 2006,289(2):329-335. |
| [23] | Grünewald FS, Prota AE, Giese A, et al. Structure-function analysis of VEGF receptor activation and the role of coreceptors in angiogenic signaling[J]. Biochim Biophys Acta, 2010,1804(3):567-580. |
| [24] | Terman BI, Dougher-Vermazen M, Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor[J]. Biochem Biophys Res Commun, 1992,187(3):1579-1586. |
| [25] | Gille H, Kowalski J, Li B, et al. Analysis of biological effects and signaling properties of flt-1 (VEGFR-1) and KDR (VEGFR-2)[J]. J Biol Chem, 2001,276(5):3222-3230. |
| [26] | Yang Z, Wang H, Jiang Y, et al. VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis[J]. Am J Pathol, 2014,184(4):1230-1239. |
| [27] | Ma W, Zhang SQ, Wei B, et al. The relationship between the levels of HDGF, VEGF and MVD in hepatocellular carcinoma, and its effect on the prognosis of patients[J]. J Bengbu Med Coll, 2018,43(2):178-180, 184. (in Chinese) |
| [27] | ( 马薇, 张书勤, 魏柏, 等. HDGF、VEGF与肝肿瘤组织MVD水平的关系及对肝癌病人预后的影响[J]. 蚌埠医学院学报, 2018,43(2):178-180, 184.) |
| [28] | Turlin B, Le Quilleuc D, Leroyer P, et al. High vascular endothelial growth factor (VEGF) expression in chemically-induced hepatic microcancers in mice[J]. J Hepatol, 2002,37(5):620-624. |
| [29] | Sakamoto H, Sakamaki T, Kanda T, et al. Vascular endothelial growth factor is an autocrine growth factor for cardiac myxoma cells[J]. Circ J, 2004,68(5):488-493. |
| [30] | Knizetova P, Ehrmann J, Hlobilkova A, et al. Autocrine regulation of glioblastoma cell-cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay[J]. Cell Cycle, 2008,7(16):2553-2561. |
| [31] | Barr MP, Gray SG, Gately K, et al. Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer[J]. Mol Cancer, 2015,14:45. |
| [32] | Hemer S, Konrad C, Spiliotis M, et al. Host insulin stimulates Echinococcus multilocularis insulin signalling pathways and larval development[J]. BMC Biol, 2014,12:5. |
| [33] | Tsai IJ, Zarowiecki M, Holroyd N, et al. The genomes of four tapeworm species reveal adaptations to parasitism[J]. Nature, 2013,496(7443):57-63. |
| [34] | Spiliotis M, Konrad C, Gelmedin V, et al. Characterisation of EmMPK1, an ERK-like MAP kinase from Echinococcus multilocularis which is activated in response to human epidermal growth factor[J]. Int J Parasitol, 2006,36(10/11):1097-1112. |
| [35] | Zavala-Góngora R, Kroner A, Bernthaler P, et al. A member of the transforming growth factor-beta receptor family from Echinococcus multilocularis is activated by human bone morphogenetic protein 2[J]. Mol Biochem Parasitol, 2006,146(2):265-271. |
| [36] | Epping K, Brehm K. Echinococcus multilocularis: molecular characterization of EmSmadE, a novel BR-Smad involved in TGF-β and BMP signaling[J]. Exp Parasitol, 2011,129(2):85-94. |
| [37] | Lu KV, Chang JP, Parachoniak CA, et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex[J]. Cancer Cell, 2012,22(1):21-35. |
| [38] | Simon T, Gagliano T, Giamas G. Direct effects of anti-angiogenic therapies on tumor cells: VEGF signaling[J]. Trends Mol Med, 2017,23(3):282-292. |
| [39] | Keklikoglou I, Kadioglu E, Bissinger S, et al. Periostin limits tumor response to VEGFA inhibition[J]. Cell Rep, 2018,22(10):2530-2540. |
| [40] | Yuan MM, Song XX, Lv W, et al. Effect of anacardic acid against echinococcosis through inhibition of VEGF-induced angiogenesis[J]. Vet Res, 2019,50(1):3. |
/
| 〈 |
|
〉 |